According to Cross Country Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 4.65678. At the end of 2021 the company had a P/E ratio of 7.73.
Year | P/E ratio | Change |
---|---|---|
2021 | 7.73 | -131.38% |
2020 | -24.6 | 241.38% |
2019 | -7.22 | -53.72% |
2018 | -15.6 | -228.33% |
2017 | 12.2 | -79.76% |
2016 | 60.0 | -48.72% |
2015 | 117 | -1056.83% |
2014 | -12.2 | 36.08% |
2013 | -8.99 | 156.62% |
2012 | -3.50 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.